Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NYSE: BSX

Boston Scientific Corporation

Healthcare | Medical - Devices

Market prices for BSX are shown to signed-in users (sign in). This public page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

EPS (TTM)$2.47

Boston Scientific Corporation (NYSE: BSX) is a medical device company. Figures from SEC EDGAR; updated 2026-10-18 15:12 UTC.

What Boston Scientific Corporation does

Boston Scientific Corporation is a medical device manufacturer that develops, manufactures and markets devices used across multiple medical specialties including cardiovascular, respiratory, digestive, oncological, neurological and urological conditions. The company operates through two reportable segments: MedSurg, which includes endoscopy, urology and neuromodulation businesses, and Cardiovascular, which focuses on interventional cardiology and vascular therapies.

Summarized from Boston Scientific Corporation’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Key facts

Valuation
EPS (TTM)$2.47
Return on equity11.96%
Debt/equity0.44

Operating Metrics

How we read this →

Boston Scientific Corp. (BSX) reported 2 operating metrics for Q1 2026 in its SEC earnings exhibit filed 2026-04-22.

Most recent reported period: Q1 2026, filed 2026-04-22.

Segment revenue$5.20B

See how BSX compares across the industry →

Oxford Ledge Signal — extracted from the issuer’s own SEC earnings exhibit and normalized by Oxford Ledge; as reported by the issuer per regulatory convention, not re-audited by us. Source: SEC EDGAR ↗

Growth rates

How we read this →
Revenue growth+11.6%

Every figure in this table is a CHANGE the issuer reported for the period, not a level. Growth rates and levels never share a column or a table -- a change read as a level is a different number entirely.

Oxford Ledge Signal — extracted from the issuer’s own SEC earnings exhibit and normalized by Oxford Ledge; as reported by the issuer per regulatory convention, not re-audited by us. Source: SEC EDGAR ↗

Revenue, margins & earnings

FY2021 Net income: $985MFY2021 Taxes & interest: $214MFY2021 Operating expenses: $6.98BFY2021 Cost of revenue: $3.71B$11.9BFY2021FY2022 Net income: $642MFY2022 Taxes & interest: $1.01BFY2022 Operating expenses: $7.08BFY2022 Cost of revenue: $3.96B$12.7BFY2022FY2023 Net income: $1.57BFY2023 Taxes & interest: $773MFY2023 Operating expenses: $7.55BFY2023 Cost of revenue: $4.34B$14.2BFY2023FY2024 Net income: $1.85BFY2024 Taxes & interest: $750MFY2024 Operating expenses: $8.89BFY2024 Cost of revenue: $5.26B$16.7BFY2024FY2025 Net income: $2.90BFY2025 Taxes & interest: $715MFY2025 Operating expenses: $10.2BFY2025 Cost of revenue: $6.22B$20.1BFY2025
  • Net income
  • Taxes & interest
  • Operating expenses
  • Cost of revenue
Annual revenue; bands show net, operating, gross margins · Open in Platform →
Net income for FY2021, FY2022, FY2023, FY2024, FY2025 is the filer’s available-to-common figure (net of preferred dividends) — the filer tags no parent net income for those years.

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-09-03
  • 2026-09-03EVP, Global OperationsTax withholding-567$27.4K
  • 2026-09-03EVP, Global OperationsOption exercise1,171—
  • 2026-09-03EVP, Global OperationsRestricted Stock UnitsOption exercise-1,171—
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →

Questions this page answers

What does Boston Scientific Corporation do?

Boston Scientific Corporation is a medical device manufacturer that develops, manufactures and markets devices used across multiple medical specialties including cardiovascular, respiratory, digestive, oncological, neurological and urological conditions.

When did BSX last file with the SEC?

Boston Scientific Corporation's most recent SEC filing on record is a 8-K filed 2026-05-18. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-18 15:12 UTC. This page is also available as JSON at /api/data?ticker=BSX and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for BSX and 5,000+ tickers.

Create a free account — keep BSX
For your agent
GET /api/data?ticker=BSX

This page as JSON via rel="alternate" · REST API docs · MCP server (62 tools) · llms.txt